Brief: Atara Biotherapeutics Q4 EPS USD -0.56
28/03/2024 12:30
Mar 28 (Reuters) - Atara Biotherapeutics Q4 net income USD -60.45 million. * Q4 operating income USD -59.962 million * Q4 revenue USD 4.189 million
Recent news on Atara Biotherapeutics
See all newsBrief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing
Atara Biotherapeutics Q1 revenue drops after prior-year one-time gain
Brief: Atara Biotherapeutics Q1 EPS USD -0.29
NASDAQ RESUMED AT 03:40 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:30 PM